Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2020; 56(03): 154-160
DOI: 10.1055/s-0040-1714328
Review Article

Treatment Modalities in the Intensive Care Unit for Coronavirus Disease 2019

Anjan Trikha
1   Department of Anaesthesiology, Pain Medicine & Critical Care, All India Institute of Medical Sciences, New Delhi, India
,
Akhil Kant Singh
1   Department of Anaesthesiology, Pain Medicine & Critical Care, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations
› Further Information
   Permissions and Reprints

The last Influenza pandemic of 1918 happened before the advent of modern medicine. We have come a long way since then. But the COVID-19 pandemic has still caught us unprepared on many fronts. The review focuses on the management of critically ill COVID-19 patients and the various treatment modalities being employed to counter this incompletely understood disease.

Keywords

COVID-19 - pneumonia - viral - respiratory distress syndrome - adult


Publication History

Article published online:
15 July 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Coronavirus Update (Live). 4,924,208 cases and 320,807 deaths from COVID-19 virus pandemic - Worldometer. Available at: https://www.worldometers.info/coronavirus/. Accessed May 19, 2020
  • 2 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA 2020; 323 (13) 1239-1242
    CrossrefPubMedGoogle Scholar
  • 3 Mortality Analyses. Johns Hopkins Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/data/mortality. Accessed May 7, 2020
  • 4 Wilson MP, Jack AS. Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: a scoping review of the early literature. Clin Neurol Neurosurg 2020; 193: 105866
    CrossrefPubMedGoogle Scholar
  • 5 Couzin-Frankel J. The mystery of the pandemic’s ‘happy hypoxia’. Science 2020; 368 (6490) 455-456
    CrossrefPubMedGoogle Scholar
  • 6 Simonnet A, Chetboun M, Poissy J. et al. LICORN and the Lille COVID-19 and Obesity study group. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020; 28 (07) 1195-1199
    Google Scholar
  • 7 Richardson S, Hirsch JS, Narasimhan M. et al. and the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323 (20) 2052-2059
    CrossrefPubMedGoogle Scholar
  • 8 Grasselli G, Zangrillo A, Zanella A. et al. COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020; 323 (16) 1574-1581
    Google Scholar
  • 9 Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020; 46 (05) 837-840
    CrossrefPubMedGoogle Scholar
  • 10 Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223) 507-513
    CrossrefPubMedGoogle Scholar
  • 11 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223) 497-506
    CrossrefPubMedGoogle Scholar
  • 12 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
    CrossrefPubMedGoogle Scholar
  • 13 Wang L-Z, Hu X-X, Liu X, Qian P, Ge J-M, Tang B-L. Influence of epidural dexamethasone on maternal temperature and serum cytokine concentration after labor epidural analgesia. Int J Gynaecol Obstet 2011; 113 (01) 40-43
    CrossrefPubMedGoogle Scholar
  • 14 Guérin C, Reignier J, Richard J-C. et al. PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368 (23) 2159-2168
    Google Scholar
  • 15 Caputo ND, Strayer RJ, Levitan R. Early self-proning in awake, non-intubated patients in the emergency department: a single ED’s experience during the COVID-19 pandemic. Acad Emerg Med 2020; 27 (05) 375-378
    CrossrefPubMedGoogle Scholar
  • 16 Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care 2020; 24 (01) 28
    CrossrefPubMedGoogle Scholar
  • 17 Rochwerg B, Brochard L, Elliott MW. et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50 (02) 1602426
    CrossrefPubMedGoogle Scholar
  • 18 Cabrini L, Landoni G, Zangrillo A. Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet 2020; 395 (10225) 685
    CrossrefPubMedGoogle Scholar
  • 19 Winck JC, Ambrosino N. COVID-19 pandemic and non invasive respiratory management: every goliath needs a David. An evidence based evaluation of problems. Pulmonology 2020; S2531-0437 (20) 30093-3
    Google Scholar
  • 20 Lucchini A, Giani M, Isgrò S, Rona R, Foti G. The “helmet bundle” in COVID-19 patients undergoing non invasive ventilation. Intensive Crit Care Nurs 2020; 58: 102859
    CrossrefPubMedGoogle Scholar
  • 21 Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7 (04) e35797
    Google Scholar
  • 22 Orser BA. Recommendations for endotracheal intubation of COVID-19 patients. Anesth Analg 2020; 130 (05) 1109-1110
    CrossrefPubMedGoogle Scholar
  • 23 Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier enclosure during endotracheal intubation. N Engl J Med 2020; 382 (20) 1957-1958
    Google Scholar
  • 24 Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1301-1308
    CrossrefPubMedGoogle Scholar
  • 25 de Wit M, Pedram S, Best AM, Epstein SK. Observational study of patient-ventilator asynchrony and relationship to sedation level. J Crit Care 2009; 24 (01) 74-80
    CrossrefPubMedGoogle Scholar
  • 26 Thille AW, Rodriguez P, Cabello B, Lellouche F, Brochard L. Patient-ventilator asynchrony during assisted mechanical ventilation. Intensive Care Med 2006; 32 (10) 1515-1522
    CrossrefPubMedGoogle Scholar
  • 27 Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med 1987; 15 (05) 462-466
    Google Scholar
  • 28 Downs JB, Stock MC. Airway pressure release ventilation: a new concept in ventilatory support. Crit Care Med 1987; 15 (05) 459-461
    CrossrefPubMedGoogle Scholar
  • 29 Putensen C, Zech S, Wrigge H. et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001; 164 (01) 43-49
    CrossrefPubMedGoogle Scholar
  • 30 Phua J, Weng L, Ling L. et al. Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020; 8 (05) 506-517
    CrossrefPubMedGoogle Scholar
  • 31 Noah MA, Peek GJ, Finney SJ. et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306 (15) 1659-1668
    CrossrefPubMedGoogle Scholar
  • 32 Alshahrani MS, Sindi A, Alshamsi F. et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 2018; 8 (01) 3
    CrossrefPubMedGoogle Scholar
  • 33 Hong X, Xiong J, Feng Z, Shi Y. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?. Int J Infect Dis 2020; 94: 78-80
    CrossrefPubMedGoogle Scholar
  • 34 Alhazzani W, Møller MH, Arabi YM. et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intens Care Med 2020; 46 (05) 854-887
    CrossrefPubMedGoogle Scholar
  • 35 Clinical management of severe acute respiratory infection when COVID-19 is suspected. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed May 8, 2020
  • 36 Rhodes A, Evans LE, Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45 (03) 486-552
    Google Scholar
  • 37 COVID-19 and VTE-Anticoagulation - Hematology.org. Available at: https://www.hematology.org:443/covid-19/covid-19-and-vte-anticoagulation. Accessed May 8, 2020
  • 38 Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam JS, Lim WS. Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. J Infect Dis 2015; 212 (02) 183-194
    CrossrefPubMedGoogle Scholar
  • 39 Corman VM, Albarrak AM, Omrani AS. et al. Viral shedding and antibody response in 37 patients with middle east respiratory syndrome coronavirus infection. Clin Infect Dis 2016; 62 (04) 477-483
    PubMedGoogle Scholar
  • 40 Arabi YM, Mandourah Y, Al-Hameed F. et al. Saudi Critical Care Trial Group. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 2018; 197 (06) 757-767
    CrossrefPubMedGoogle Scholar
  • 41 Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015; 386 (9997) 995-1007
    CrossrefPubMedGoogle Scholar
  • 42 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Available at: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and- management/. Accessed May 8, 2020
  • 43 Revised National Clinical Management Guideline for COVID 1931032020.pdf. Available at: https://www.mohfw.gov.in/pdf/RevisedNationalClinicalManagementGuidelineforCOVI D1931032020.pdf. Accessed May 10, 2020
  • 44 Geleris J, Sun Y, Platt J. et al. Observational study of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med 2020; 382 (25) 2411-2418
    CrossrefPubMedGoogle Scholar
  • 45 Amsden GW. Anti-inflammatory effects of macrolides–an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?. J Antimicrob Chemother 2005; 55 (01) 10-21
    CrossrefPubMedGoogle Scholar
  • 46 Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020; 178: 104787
    CrossrefPubMedGoogle Scholar
  • 47 Patrì A, Fabbrocini G. Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and treatment?. J Am Acad Dermatol 2020; 82 (06) e221
    CrossrefPubMedGoogle Scholar
  • 48 Sheahan TP, Sims AC, Graham RL. et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 2017; 9 (396) eaal3653
    CrossrefPubMedGoogle Scholar
  • 49 Cao B, Wang Y, Wen D. et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 2020; 382 (19) 1787-1799
    CrossrefPubMedGoogle Scholar
  • 50 Mair-Jenkins J, Saavedra-Campos M, Baillie JK. et al. Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2015; 211 (01) 80-90
    CrossrefPubMedGoogle Scholar
  • 51 Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism. Crit Care 2017; 21 (01) 25
    CrossrefPubMedGoogle Scholar
  • 52 Nguyen TC, Carcillo JA. Bench-to-bedside review: thrombocytopenia-associated multiple organ failure–a newly appreciated syndrome in the critically ill. Crit Care 2006; 10 (06) 235
    Google Scholar
  • 53 Knaup H, Stahl K, Schmidt BMW. et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care 2018; 22 (01) 285
    CrossrefPubMedGoogle Scholar
  • 54 Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Crit Care 2020; 24 (01) 128
    CrossrefPubMedGoogle Scholar
  • 55 Ma J, Xia P, Zhou Y. et al. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clin Immunol 2020; 214: 108408
    CrossrefPubMedGoogle Scholar
  • 56 Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp 2018; 6 (01) 12
    CrossrefPubMedGoogle Scholar